A clinician’s eye, a leader’s perspective
Discover how Ola Kotun’s clinical, operational and advisory experience shapes a measured approach to healthcare decisions worldwide.
Ola Kotun’s career has moved through the places where healthcare is delivered, designed and governed. She began in nursing, then widened her view through clinical technology, operating models, consulting and entrepreneurship. That path gives her biography an unusual shape: it is grounded in patient-facing work, yet attentive to the systems and decisions surrounding it.
Today, she is founder of Five Delphi, an independent, evidence-led medical concierge for high-stakes decisions worldwide. The service is described as confidential and works with principals and their households across the UK, Europe, the Gulf, North America and Africa. Its place on this page is important because it shows leadership as a practice of careful navigation, not a claim to replace a person’s clinicians or make decisions on their behalf.
Earlier roles included national clinical operating-model leadership across three health systems spanning 27 hospitals and 128 wellbeing centres. Her existing professional biography reports a 10% cost reduction, a 6% throughput gain and improved patient outcomes in that leadership work. It also records health advisory work at KPMG, where she won more than £2m in fees, and a Head of Health role at a global innovation firm, building and scaling its Health & Life Sciences practice across eight countries.
Her founder chapter includes 1Dokita, identified by F6S as a Lagos-based healthcare technology company founded in 2016, and SAILE, described here as an adviser on healthcare systems. Five Delphi is the current flagship. Across those ventures, the stated throughline is better decisions, fairer access and higher standards in care. The distinction matters: the page presents a sequence of leadership responsibilities rather than treating one enterprise as the whole story.
Ola has served as a GLG Expert Council member since 2022, advising private equity, sovereign wealth and corporate clients on healthcare investment, clinical operating models and provider quality. In July 2024, she was appointed Board Trustee and VP Membership of PWN London, the UK arm of a 4,000-member federation across 25 European cities. She is also described as an AI healthcare expert adviser, bringing clinical judgement, governance and provider knowledge to model output.
Her formal education includes an Executive MBA in Healthcare at Warwick Business School, an MSc in Occupational Health with Distinction and a BSc in Nursing from the University of Birmingham, alongside executive leadership programmes at Harvard and Yale. Warwick records her Executive MBA attendance from 2020 to 2022. Read together, these details explain the vantage offered here: bedside experience, board responsibility and boardroom perspective, held together by a commitment to clearer healthcare decisions.